"Tired of suffering from painful and recurring headaches? We specialize in headache treatment and provide a wide range of methods to give you relief. Our team of certified specialists can pinpoint the source of your pain and address it, formulating a treatment plan customized to your needs. Call to schedule an appointment with our migraine doctors, headache specialists, and headache physicians today."

During the past decade, Chicago Headache Center & Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chicago Headache Center & Research Institute" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Chicago Headache Center & Research Institute" with 1 trials sponsored and "Theranica" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chicago Headache Center & Research Institute" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chicago Headache Center & Research Institute" are "Migraine" (6 trials), "Acute Treatment of Migraine" (1 trials), "Episodic Migraine" (1 trials), "Headache, Migraine" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "Chicago Headache Center & Research Institute" in a lesser frequency.

Most popular intervention types in "Chicago Headache Center & Research Institute" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Erenumab" (2 trials), "Lasmiditan" (2 trials), "Galcanezumab" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chicago Headache Center & Research Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Chicago Headache Center & Research Institute". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Chicago Headache Center & Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chicago Headache Center & Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".